A Better "Buy the Dips Nasdaq" by Garen Phillips
Today’s Change (Nov 22, 2026)
—
A symphony is an automated trading strategy — Learn more about symphonies here
About
An aggressive market-timing strategy that usually holds a concentrated tech/growth basket, but switches to a bearish Nasdaq fund when tech looks too hot and to leveraged biotech when tech looks deeply sold off.
This strategy watches the Nasdaq-100 through QQQ. If tech looks very overheated, it bets against it with SQQQ. If tech looks heavily sold off, it may buy LABU, a very aggressive biotech fund, for a rebound. Otherwise it owns an equal mix of TQQQ plus big growth names like Apple, Microsoft, Amazon, Nvidia, AMD, Tesla, and TSM.
It uses simple price rules: recent % moves and RSI, which is a 0–100 “hot or cold” gauge of recent trading.
Out-of-sample, this tactical Nasdaq strategy aims for higher upside than the S&P: ~34% annualized return vs ~13%, and Sharpe ~0.89 vs ~0.83. Expect larger drawdowns (~47%). Best for risk-tolerant, active investors.
Loading backtest data...
Invest in this strategy
OOS Start Date
Mar 18, 2024
Trading Setting
Threshold 10%
Type
Stocks
Category
Tactical asset allocation, nasdaq, leveraged etfs, growth stocks, mean reversion, momentum, inverse etf, biotech
Tickers in this symphonyThis symphony trades 11 assets in total
Ticker
Type
AAPL
Apple Inc
Stocks
AMD
Advanced Micro Devices Inc.
Stocks
AMZN
Amazon.com Inc.
Stocks
LABU
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF
Stocks
MSFT
Microsoft Corporation
Stocks
NVDA
NVIDIA Corp
Stocks
QQQ
Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1
Stocks
SQQQ
ProShares Trust - ProShares UltraPro Short QQQ -3x Shares
Stocks
TQQQ
ProShares Trust - ProShares UltraPro QQQ 3x Shares
Stocks
TSLA
Tesla Inc
Stocks